David Bernstein

4.2k total citations
50 papers, 1.6k citations indexed

About

David Bernstein is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Bernstein has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 28 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in David Bernstein's work include Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (23 papers) and Hepatitis B Virus Studies (14 papers). David Bernstein is often cited by papers focused on Hepatitis C virus research (31 papers), Liver Disease Diagnosis and Treatment (23 papers) and Hepatitis B Virus Studies (14 papers). David Bernstein collaborates with scholars based in United States, United Kingdom and Germany. David Bernstein's co-authors include K. Rajender Reddy, Eugene R. Schiff, Arthur E. Pitchenik, Elena S. Hollender, Denis Jones, David Ashkin, Mark Sulkowski, Nancy S. Shulman, Lennox J. Jeffers and K. Peter Etzkorn and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

David Bernstein

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Bernstein United States	20	1.1k	1.0k	348	251	179	50	1.6k
Fabio Tinè Italy	15	1.2k 1.1×	1.2k 1.2×	32 0.1×	408 1.6×	11 0.1×	33	1.5k
M. J. H. Slooff Netherlands	21	480 0.4×	396 0.4×	61 0.2×	569 2.3×	6 0.0×	59	1.2k
William M. Lee United States	14	811 0.7×	658 0.7×	70 0.2×	153 0.6×	5 0.0×	17	1.1k
Edward Lebovics United States	16	431 0.4×	464 0.5×	123 0.4×	238 0.9×	7 0.0×	68	837
S. Agnes Italy	22	1.2k 1.1×	774 0.8×	72 0.2×	886 3.5×	12 0.1×	102	1.7k
Giuseppe Tisone Italy	19	955 0.9×	666 0.7×	63 0.2×	667 2.7×	9 0.1×	63	1.5k
G Leitz United States	19	190 0.2×	620 0.6×	584 1.7×	157 0.6×	6 0.0×	59	1.4k
Robert L. Carithers United States	17	914 0.8×	1.1k 1.1×	47 0.1×	247 1.0×	5 0.0×	27	1.7k
Jan Freeman United Kingdom	18	374 0.3×	371 0.4×	15 0.0×	455 1.8×	20 0.1×	36	872
Katrina J R Watson Australia	15	393 0.4×	457 0.5×	30 0.1×	98 0.4×	36 0.2×	22	729

Countries citing papers authored by David Bernstein

Since Specialization

Citations

This map shows the geographic impact of David Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bernstein more than expected).

Fields of papers citing papers by David Bernstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bernstein. The network helps show where David Bernstein may publish in the future.

Co-authorship network of co-authors of David Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Bernstein. A scholar is included among the top collaborators of David Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bernstein. David Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poordad, Fred, Shahriar Sedghi, Paul J. Pockros, et al.. (2019). Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. Journal of Viral Hepatitis. 26(8). 1027–1030. 1 indexed citations

Lam, Jenny, Toshiaki Suzuki, David Bernstein, et al.. (2018). An ERAS protocol for bariatric surgery: is it safe to discharge on post-operative day 1?. Surgical Endoscopy. 33(2). 580–586. 32 indexed citations

Rex, Douglas K., Raj Bhandari, Taddese Desta, et al.. (2018). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointestinal Endoscopy. 88(3). 427–437.e6. 196 indexed citations

Kwo, Paul Y., Norman Gitlin, Ronald Nahass, et al.. (2016). Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study. PMC. 5 indexed citations

Pockros, Paul J., K. Rajender Reddy, Parvez Mantry, et al.. (2016). Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease. Gastroenterology. 150(7). 1590–1598. 197 indexed citations

Feld, Jordan J., Christophe Moreno, Roger Trinh, et al.. (2015). Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks. Journal of Hepatology. 64(2). 301–307. 110 indexed citations

Bernstein, David, et al.. (2015). Ribavirin does not impact health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in Treatment-NaÏve adults with Genotype 1A (GT1A) Chronic Hepatitis C. Value in Health. 18(3). A227–A227. 2 indexed citations

Bernstein, David, et al.. (2012). Direct cholangioscopy. European Journal of Gastroenterology & Hepatology. 24(12). 1406–1409. 4 indexed citations

Bernstein, David, et al.. (2012). Severe Pancreatitis Secondary to Intra-Gastric Balloon Placement. The American Journal of Gastroenterology. 107. S332–S332.

10.

Reddy, K. Rajender, Sugantha Govindarajan, Patrick Marcellin, et al.. (2007). Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon α‐2a plus ribavirin. Journal of Viral Hepatitis. 15(2). 129–136. 40 indexed citations

11.

Berg, Carl L., Fernando Lopes Gonçales, David Bernstein, et al.. (2006). Re‐treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon‐alpha‐2a (40 kDa) and ribavirin. Journal of Viral Hepatitis. 13(7). 435–440. 27 indexed citations

12.

Khalili, Mandana, et al.. (2005). Pegylated Interferon α -2a With or Without Ribavirin in HCV/HIV Coinfection: Partially Blinded, Randomized Multicenter Trial. Digestive Diseases and Sciences. 50(6). 1148–1155. 8 indexed citations

13.

Sullivan, Sean D., Donald M. Jensen, David Bernstein, et al.. (2004). Cost-Effectiveness of Combination Peginterferon alpha-2a and Ribavirin Compared With Interferon alpha-2b and Ribavirin in Patients With Chronic Hepatitis C. The American Journal of Gastroenterology. 99(8). 1490–1496. 47 indexed citations

14.

Rose, Susan R., Jeffrey Baron, David Bernstein, et al.. (2000). Suppression and Recovery of GH Secretion after GH Injection in Non-GH Deficient Short Children. Journal of Pediatric Endocrinology and Metabolism. 13(3). 281–8. 6 indexed citations

15.

Bernstein, David & Marcia Angell. (1999). The Breast Implant Fiasco. California Law Review. 87(2). 457–457. 9 indexed citations

16.

Jones, Denis, et al.. (1998). Antituberculosis Drug–induced Hepatotoxicity: The Role of Hepatitis C Virus and the Human Immunodeficiency Virus. American Journal of Respiratory and Critical Care Medicine. 157(6). 1871–1876. 215 indexed citations

17.

Dailey, Peter J., Lennox J. Jeffers, David Bernstein, et al.. (1996). Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis C. Journal of Viral Hepatitis. 3(5). 239–246. 33 indexed citations

18.

Bernstein, Jonathan A., et al.. (1996). 725 Assessment of human seminal plasma hypersensitivity prevalence in North America using a validated questionnaire. Journal of Allergy and Clinical Immunology. 97(1). 364–364. 1 indexed citations

19.

Jeffers, Lennox J., David Bernstein, K. Rajender Reddy, et al.. (1995). Hepatitis C Virus in Alcoholic Patients with and without Clinically Apparent Liver Disease. Alcoholism Clinical and Experimental Research. 19(5). 1173–1176. 69 indexed citations

20.

Bernstein, David, Robert I. Goldberg, & S. W. Unger. (1994). Common bile duct obstruction following T-tube placement at laparoscopic cholecystectomy. Gastrointestinal Endoscopy. 40(3). 362–365. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact